Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

Aer Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class inhaled therapies that target mucus obstruction in chronic lung diseases.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

Axonis Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule therapies that target KCC2

view more →

Their clinical research software accelerates timelines by automating multiple high impact processes.

view more →

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases

view more →

Cardiosense combines multimodal wearable sensors with AI to noninvasively detect early signs of cardiac disease and guide personalized therapy.

view more →

Code Bio is a preclinical stage company developing novel genetic medicines.

view more →

Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.

view more →

Gozio Health is a digital health company that provides a customizable, mobile engagement platform for health systems

view more →

Huma.AI is a life sciences–focused generative AI company that provides a secure knowledge platform

view more →

MMvention Therapeutix, Inc. is an early-stage biotechnology company focused on discovering and developing novel oral small-molecule therapeutics

view more →

iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software

view more →

Mercy BioAnalytics is a biotechnology company developing blood-based tests for the early detection of cancer

view more →

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain

view more →

Ten63 Therapeutics is a computational drug discovery company leveraging its proprietary AI- and physics-based platform to design novel therapeutics

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910